Narrative review / 2013
A review outlines epidemiological research pathways for amyotrophic lateral sclerosis, including potential risk factors like smoking, statins, and BMAA.
This review discusses the current status, challenges, and novel study design options in amyotrophic lateral sclerosis (ALS) epidemiology. It examines findings from large-scale prospective studies, registries, neuropathologic findings, and specific risk factors such as military service, smoking, statin use, and β-N-methylamino-L-alanine (BMAA). Future directions include utilizing well-characterized cohorts of newly diagnosed patients, storing biological material, and exploring gene-environment interactions.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Individuals with or at risk for amyotrophic lateral sclerosis (ALS)
- What was measured
- Epidemiology, risk factors, and study design pathways in ALS
THE PAPER
Current pathways for epidemiological research in amyotrophic lateral sclerosis.
Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chío A, Garruto R, Hardiman O, Kamel F, Kasarskis E, McKee A, Nakano I, Nelson LM, Eisen A. Amyotroph Lateral Scler Frontotemporal Degener, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.